Despite various hypothesized benefits of dietary isoflavone genistein (GEN) from soy-based products, many questions surrounding GEN's immunotoxic effects, especially during perinatal exposure, have yet to be answered. The objective of the study was to determine if there existed a sex-specific effect of GEN on type 1 diabetes (T1D) following perinatal exposure. We exposed offspring of non-obese diabetic (NOD) mice to GEN per oral at a physiological dose (20 mg/kg body weight) from embryonic day 7 to postnatal day (PND) 21. In female offspring, perinatal GEN dosing significantly increased the incidence of T1D at early time points, and the exacerbation was associated with decreased serum levels of interleukin (IL)-10, IgG 2a , and IgM. In male offspring dosed with GEN, a decrease in serum IgG 1 was also observed. Flow cytometric analysis in females suggested an increased pro-inflammatory splenic CD5 þ
and type 2 diabetes (Gilbert and Liu, 2013) due to its immunomodulatory properties and protective effects on pancreatic b-cells in murine models while epidemiological evidences are limited to provide a solid association between GEN exposure and T1D. However, the effects of GEN on immune regulation and the onset of T1D and glucose regulation during perinatal stages have not been fully understood. Perinatal GEN treatment was found to have immunomodulatory effects in animal studies. Our group has reported changes in immune response (such as increased cytotoxic T cells activity and decreased regulatory T cells) following perinatal GEN dosing in female B6C3F1 mice, and the response depends largely on sex, exposure duration, as well as litter order (Guo et al., 2005) .
The association of high soy consumption during perinatal period and risk of T1D is uncertain and intricate. Among the limited epidemiological reports, one study showed that for infants aged 4-6 and 7-12 months, soy milk formula consumption was associated with a two-fold increase of T1D risk in China (Strotmeyer et al., 2004) , while information on other exposure windows is largely unknown. Another epidemiological study suggested twice as many diabetic children consumed soy-based formula in infancy as healthy children (Fort et al., 1986) . However, the mechanism underlying the effect of soy intake on T1D in perinatal stages is largely unknown, and studies on the gender effect are lacking.
In the fetus, early-life gut bacterial colonization plays an important role in metabolic tissue development and in influencing the risk of autoimmune diseases (Kozyrskyj and Sloboda, 2016) because intestinal immune system development starts as early as 11 weeks of gestation in humans (Mejia-Leon and de la Barca, 2015) . Bacterial DNA can transfer from mother to fetus through amniotic fluid, umbilical cord (Kozyrskyj and Sloboda, 2016) , and placenta (Romano-Keeler and Weitkamp, 2015) . There is evidence to show that modulation of gut microbiota (GMB) by probiotics (Lactobacillus rhamnosus or Bifidobacterium lactis) during pregnancy alters infant immune responses (Prescott et al., 2008) . The mode of delivery, the antibiotic used after birth, and the infant formula consumption could all help shape the infant microbiota (Mejia-Leon et al., 2015; Mueller et al., 2015; RomanoKeeler and Weitkamp, 2015) and further modulate the immune system. In mice, the colonization of thymus starts from day 10 to day 11 of gestation (Holladay and Smialowicz, 2000) . To understand the effects of perinatal GEN intake on T1D, which represented a major deficit in our present knowledge, we investigated the potential links between GEN exposure at the physiological level (20 mg/kg body weight, BW) and increased risk of developing T1D in non-obese diabetic (NOD) mice, a model that closely resembles human T1D (Anderson and Bluestone, 2005) , with regards to different exposure windows (perinatal period in conjunction with our previous findings on adults) and sex from perspectives of immunomodulation and GMB.
MATERIALS AND METHODS
Perinatal study. A total of 24 time-mated (male: female ¼ 1:1) NOD female mice with normal blood glucose level (BGL) were used and randomized into vehicle (VH) and GEN groups (12 per group) based on body weight and baseline BGL. From gestational day (GD) 7, the mice in VH group received a 0.1 ml/10 g BW sodium carbonate (Na 2 CO 3 , 25 mM) daily because of GEN's low water solubility, and the mice in GEN group were gavaged with 0.1 ml/10 g BW GEN dissolved and sonicated in VH (2 mg GEN/ml [Guo et al., 2014] till PND 21). Thus, the perinatal dosing included both in utero and lactational exposures. The daily dosing was performed with 18 G gavage needles. After parturition, the pups were housed in the same cage with dams with one litter per cage. Animal husbandry is included in the Supplementary Material. As the pups on 5K96 diet were usually smaller than the ones on regular diet, they were separated from the dams on PND 28 and housed up to five same-sex littermates per cage. Each litter was treated as an experimental unit.
In the second study, a total of 8 NOD females with normal BGL were randomized into VH (N ¼ 4) and GEN (N ¼ 4) groups, time-mated (male: female ¼ 1:2) and received the same dosing regimen as above. Gestational day 0 was defined as the plug day. These 8 females gave birth to 8 litters. This separate study was conducted for GMB analysis, transcriptomic analysis, and to verify previous results. Each litter was treated as an experimental unit. All animal procedures in the lab were approved by the UGA Institutional Animal Care and Use Committee (IACUC).
Body weight (bw) and blood glucose level (bgl) measurement. The BW and BGL were monitored every week for the NOD offspring. The non-fasting BGL was measured using a blood glucose meter (Bayer Contour, Ascensia Diabetes Care, Parsippany, New Jersey) with a small sample of venous blood sample. T1D was defined as a BGL higher than or equal to 250 mg/dl (13.9 mmol/l) (Guo et al., 2014) . Mice with BGL of 600 mg/dl or higher (33.3 mmol/l) in two consecutive weeks or at the end of the study were euthanized with carbon dioxide (CO 2 ) inhalation. Individual organs were collected and weighted during necropsy. In addition, glucose and insulin tolerance tests were performed (see Supplementary Material).
Serum antibody measurement. The enzyme-linked immunosorbent assay (ELISA) was performed to detect the total antibody levels (IgG 2a , IgG 2b , IgM, and IgG 1 ) in mouse sera according to the reported procedures (Guo et al., 2014) . Briefly, the plates were added with blocking solution (5% milk powder in PBS with Tween 20) for 1 h and washed with PBST (Tween 20 in PBS). The diluted serum was then added in the plates and incubated in room temperature for 2 h. Then the secondary antibody was added and incubated for 1 h. Substrate TMB was added at 100 ll/ well and the plate was read at the wavelength of 405 nm. Serum insulin and anti-insulin antibody were also measured and listed in the Supplementary Material. Serum cytokine and chemokine. A total of 9 cytokines (IFN-c, IL-1a, IL-1b, IL-2, IL-6, IL-10, IL-12p40, IL-12p70, TNF-a, both proinflammatory and anti-inflammatory) and 1 chemokine (MCP-1) were measured using Luminex Mouse Cytokine/Chemokine Magnetic Bead Panel (EMD Millipore Corporation, Billerica, Massacheussts) following manufacturer's protocols. Sera and beads were added, and the plates were incubated at 4 C overnight on a shaker. Then detection antibody was added and followed by streptavidin phycoerythrin. Plates were run on a BioPlex MAGPIXTM Multiplex Reader with Bio-Plex ManagerTM MP Software (Luminex, Austin, Texas). Each biomarker concentration was calculated as pg/ml.
Flow cytometry. The spleen was subject to flow cytometric analysis following mashing between two slides with frosted ends (Guo et al., 2006 16s rRNA taxonomy and diversity. The DNA extraction and sequencing are included in Supplementary Material. Bioinformatics analysis was performed as described previously with fecal DNA amplicons (Huang et al., 2017; Lefever et al., 2016) . In brief, Read 1 and Read 2 sequence files were merged with Mr_Demuxy 1.2.0 (available from https://pypi.python.org/ pypi/Mr_Demuxy), a python program designed for demultiplexing sequences with dual index, allowing a maximum difference of 15. The multiple_split_libraries.py script was then run with a default Phred offset and a Phred quality threshold of 20, allowing for 1% incorrect base call probability. The fasta file then was analyzed with Quantitative Insights into Microbial Ecology (QIIME) version 1.7.0 (Caporaso et al., 2010) . The workflows included pick_de_novo_otus.py, which picked operational taxonomic units (OTUs) based on 97% similarity, assigned taxonomy by uclust, aligned representative sequences with PyNAST, built a phylogenetic tree, and then made the OTU table. The sequences were rarified at a depth of 6000 reads, then a-diversity and b-diversity were computed with core_diversity_analysis.py. The metrics for a-diversity include PD whole tree, observed OTUs, and chao1. b-diversity was represented by both phylogeneticbased (unweighted Unifrac and weighted Unifrac) and nonphylogenetic-based (Jaccard distance and Bray-Curtis distance) (Caporaso et al., 2010) . In addition, linear discriminant analysis effect size (LEfSe) was applied to identify the most biologically informative microbial features differentiating between two treatment groups (Segata et al., 2011) RNA-sequencing (RNA-seq). As Paneth cells in ileum section can sense bacterial stimuli and initiate anti-microbial actions through peptides, the ileum tissues from NOD female offspring were harvested upon euthanasia at the end of study (PND 206) , emptied for intestinal content, transferred to liquid nitrogen and later À80 C freezer for storage. RNA was extracted using
RNeasy Mini Kit (QIAGEN), and the extracted RNA was measured for concentration, quality (as indicate by A260/280 and A260/230), and integrity (RNA integrity number greater than 6). The RNA was then submitted to Genewiz (South Plainfield, New Jersey) for quality control, DNA removal, library preparation, and sequencing with Illumina Hi-seq (San Diego, CA), which yielded 2X150 pair-end reads (total ¼ 372 034 607 with a mean quality score of 37.48). The subsequent steps were performed in Georgia Advanced Computing Resource Center (GACRC): First, the data passed the quality control via FastQC; then the lowquality reads and adapters were trimmed by Trimmomatic (Bolger et al., 2014) , with >90% pair-end reads survived. The reads were aligned with the mouse reference genome mm10, available at https://genome.ucsc.edu/cgi-bin/hgGateway? db¼mm10) using Tophat 2.1.1 (Trapnell et al., 2009 ) allowing for a minimum intron length of 20 and a maximum intron length of 500 000. Subsequently the mapped reads were searched for differentially expressed genes (DEGs) in transcript expression using Cuffdiff (Trapnell et al., 2010) . The DEGs were identified with a q value less than 0.05.
Quantitative real-time PCR (qRT-PCR) for mRNA expression. To confirm RNA-seq results that there were actual changes in a-defensin mRNA, qRT-PCR was used. RNA was extracted as described in RNA-seq section, and RNA isolates were reverse transcribed to cDNA with the iScript TM cDNA synthesis kit (Bio-Rad). The cDNA obtained was used for real-time PCR analysis. The qRT-PCR assays were performed in 1 ll reactions containing 5 ll SYBR Green I Master and 1 ll gene-specific primers (described in Supplementary Table 1) . Samples were analyzed in technical triplicate using a Stratagene Mx3005 qPCR thermocycler (Agilent Technologies, La Jolla, California).
Histology. The histology of pancreas was evaluated by a boardcertified veterinary pathologist (Dr Nagy). The details of histologic analysis were described in the Supplementary Material.
Statistical analysis. Dunnett's test was used for comparisons with VH as reference group when the equal variance assumption was met; otherwise, Wilcoxon test was performed. Likelihood ratio was performed for comparing diabetes incidence between groups. In LEfSe analysis, Kruskal-Wallis and Wilcoxon tests were used for logarithmic LDA scores >2.0 with a critical value of 0.05. JMP Pro 12 (SAS Inc., Cary, North Carolina), GraphPad Prism 7 (GraphPad Software Inc., La Jolla, California), and R 3.3.1 (R Core Team, 2013) were used for statistical analysis and data visualization.
RESULTS

T1D Incidence Was Increased in Female, but Not in Male Offspring, Following Perinatal GEN Dosing
Female offspring perinatally dosed with GEN (from GD7 to PND 21) had a significant earlier onset of T1D ( Figure 1A ), and the incidence of T1D in GEN-treated group was twice as much as that in VH group from PND 100 to PND 175; significant increases in the incidence of T1D were observed at PND 113 (24% vs 3%), 120 (24% vs 6%), 147 (39% vs 16%), and 162 (45% vs 23%). The incidence of severe T1D (BGL ! 400 mg/dl) was also increased at PND 113 (33% vs 4%), 120 (33% vs 8%), 125 (38% vs 12%), 147 (54% vs 20%), 162 (63% vs 28%), and 168 (67% vs 36%) (Supplementary Figure 1) . In addition to T1D incidence, perinatal GEN treatment exacerbated BGL in non-diabetic female offspring on PND 64, 203, and 274 ( Figure 1B ). However, the T1D incidence in males ( Figure 1C ) and the BGL in non-diabetic males ( Figure 1D ) were not significantly affected by the GEN treatment. Taken together, administration of GEN during early postnatal development caused a detrimental effect in female offspring (both the onset of T1D and the BGL), but not in the male offspring.
Perinatal GEN Dosing Elicited a Pro-inflammatory Response in
Females While an Anti-inflammatory Response in Males Serum antibody levels were altered following perinatal GEN dosing (Figure 2 ): Among the four antibodies measured (IgG 1 , IgG 2a , IgG 2b , and IgM), IgG 2a was decreased by 5.7% (p < .05, Figure 2A ), and IgM was decreased by 16.4% (p < .01, Figure 2C ) in female offspring. Among male offspring, serum IgG 1 level was reduced by 13.6% (p < .05, Figure 2H ). and male offspring were measured at dilutions of 1:50, 1:50, 1:500, and 1:5000 (v/v), respectively, following titration by serial dilution using ELISA. The sera were obtained when the mice were euthanized. *, p < .05 and **, p < .01. Each of the serum antibody concentration was calculated as the percent control. VHF, females exposed to vehicle control (N ¼ 21); GEF, females exposed to GEN (N ¼ 16); VHM, males exposed to vehicle control (N ¼ 10); GEM, males exposed to GEN (N ¼ 16). GEN, genistein; ELISA, enzyme-linked immunosorbent assay.
subpopulation (representing cytotoxic T cells; Figure 3D ) was observed. The alterations of total T cells and B cells did not achieve statistical significances (p > .05; data not shown). Splenic T cell and its subpopulation were also analyzed in male offspring for comparison. Following perinatal GEN dosing, both the percentages of CD3 Figure 4A ) were significantly reduced, while the CD4 À CD8 þ subpopulation was not altered (data not shown). B cell population and its subtypes did not show a difference (data not shown). Among the 9 cytokines (IFN-c, IL-1a, IL-1b, IL-2, IL-6, IL-10, IL12p40, IL-12p70, and TNF-a) and 1 chemokine (MCP-1) analyzed in this study, there was no significant difference in most cytokines/chemokines except for serum IL-10, which was noticeably reduced (by 8.9%) in female offspring following perinatal GEN dosing (Table 1) . However, no significant changes were observed in male offspring in either the cytokines or chemokine measured (Table 1) .
Gut Microbiota Was Perturbed Toward a Pro-inflammatory
Response Among Female Offspring, But Toward an Anti-inflammatory Response Among Male Offspring at PND 90 Fecal samples from both PND 30 and PND 90 female offspring were used for 16s rRNA sequencing. At the phylum level, the ratio of Bacteroides/Firmicutes was numerically decreased (p > .05) following GEN (GEF) dosing compared with VH (VHF) at PND 30 in female offspring (2.63 in GEF and 2.70 in VHF; Supplementary  Figure 2A) . No alteration in both a diversity and taxonomy at either order or genus level was observed (data not shown). Furthermore, principal coordinate analysis (PCoA) did not show a significant difference in the bacterial community composition at PND 30 between GEN and VH-treated females with both unweighted Unifrac metric (data not shown) and weighted Unifrac ( Figure 5A ).
At PND 90, the Bacteroides/Firmicutes ratio was nonsignificantly decreased from 2.38 in VHF to 1.47 in GEF in female offspring (GEF vs VHF at PND 90: p ¼ .088 by Wilcoxon test; Supplementary Figure 2B) , indicating that the taxonomy at phylum level was not significantly affected by GEN treatment within first 3 months. In addition, a-diversity remained unchanged following perinatal GEN dosing in PND 90 females (p > .05, data not shown). However, at PND 90, GEN-treated mice could be well separated by weighted Unifrac, a phylogeneticbased metric that takes bacterial abundance into account ( Figure 5B , p ¼ .045 by non-parametric test). In addition, Enterobacterials at the order level ( Figure 5C ) was significantly increased following perinatal GEN dosing at PND 90 (LDA score > 2.0, p < .05 by non-parametric test). The non-phylogeneticbased metrics did not show a difference (data not shown).
Fecal samples from PND 90 male offspring were also used for 16s rRNA sequencing. In male offspring, taxonomy at phylum level ( Figure 6A ), unweighted (data not shown) and weighted Unifrac ( Figure 6B ) did not show a difference at PND 90, while an increased genus Parabacteroides was found in males perinatally dosed with GEN ( Figure 6C ). At order level, no alteration in taxonomy was observed, and the non-phylogenetic-based metrics did not show a difference (data not shown).
RNA-seq Identified Down-Regulation of Multiple Defensin Subclasses and Other Inflammatory Markers
To explore further the mechanism of pro-inflammatory immune response following perinatal GEN dosing in female offspring, a transcriptomic study was conducted. A total of 124 out of 35 607 genes were identified with a p-value less than 0.05. Significantly up-regulated and down-regulated genes from RNA-seq were shown in Supplementary Table 2. Noticeably and consistently, perinatal GEN dosing in NOD female offspring down-regulated Defa17, Defa24, Defa29, and Defa30, which were confirmed by examining their mRNA levels using quantitative PCR analyses (p ¼ .01, Figs. 7A and 7B ).
DISCUSSION
T1D, a devastating and expensive organ-specific autoimmune disease, is increasing in incidence in U.S. adults (once mainly in juveniles) with 40% excess risk of death in women (Huxley et al., 2015; Li et al., 2016a) . Environmental exposure (eg endocrine disruptors) and genetic predisposition may be the underlying causes (Jobling et al., 2013) . Soy milk formula consumption during infancy was associated with a two-fold higher risk of T1D (Fort et al., 1986; Strotmeyer et al., 2004 ) and a significant increase in use of asthma or allergy drugs in young women (Strom et al., 2001) . Our studies have identified unique windows of T1D susceptibility in female NOD mice for GEN: perinatal GEN dosing (from GD 7 to PND 21) accelerated the onset of T1D. In contrast, similar detrimental effect was not found in males, and adult GEN dosing were protective in both sexes (Huang et al., 2017) . Although the mechanisms underlying a fetal basis of adult T1D are currently unclear, sex differences in immunoregulation in early life (Bao et al., 2002) and GMB-driven estrogen metabolism (Markle et al., 2013) might be responsible for our observations that female offspring dosed with GEN perinatally showed an exacerbation of T1D. The dose selected in this study is physiologically relevant because soy formula can provide a 4-month-old infant with approximately 6-9 mg/kg of isoflavones (Irvine et al., 1998) . The dose of 20-mg/kg GEN in mice is much lower than a clinical human supplement dose (approximately 100 mg/day [Djuric et al., 2001] ) in terms of milligrams per square meter of body surface, which often gives more accurate interspecies extrapolation (Hodgson and Levi, 2010) . The serum level of GEN (1.4-7.5 lM) in rodents that have been fed a 1000 ppm GEN-containing diet (about 80-mg/kg BW) was equivalent to that in men who received 100-mg GEN/day (Bhandari et al., 2003; Djuric et al., 2001; Yellayi et al., 2002) .
Evidences in both humans and animal models increasingly suggest that T1D is originated in the gut (70% of the body's immune system dwells here) and associated with a profound dysbiosis during the perinatal period and in adulthood, favoring pro-inflammatory microbial communities (Kostic et al., 2015; Markle et al., 2013; Vaarala et al., 2008) . In NOD mice, differences in sex hormones and GMB underlie its sexual dimorphism of T1D (Yurkovetskiy et al., 2013) . Thus, an intricate interplay between of perinatal GEN intake, GMB, immune dysregulation, and sex hormone imbalance (Gourdy et al., 2016) may play critical roles in the T1D exacerbation. Our current study revealed that perinatal GEN dosing perturbed the GMB toward a proinflammatory response in females at PND 90, but not at PND 30, in addition to altering the b-diversity. In males, however, perinatal GEN dosing perturbed the GMB toward an antiinflammatory response at PND 90. Our study is the first to identify the unique window of effect for GMB alteration. For inflammatory status following perinatal GEN dosing, the increase in Enterobacterials at the order level and Enterobacteriaceae at the genus level in females were associated with a pro-inflammatory status (Ellis et al., 2011) , while an increased genus Parabacteroides was found in males, indicating a modulating effect on immune system and possibly regulatory T cells (Li et al., 2016b) . To date, the only study investigating GMB alteration induced by perinatal endocrine disruptor exposure found bisphenol A perturbed b-diversity in rabbits on PND 42 (Reddivari et al., 2017) . With regards to antibody and cytokine alterations, there was evidence that IgG 2a demonstrated an anti-inflammatory effect and thus protected female NOD mice from T1D (Todd et al., 1998) . In our studies, we observed a decrease in IgG 2a in NOD females following perinatal GEN dosing, suggesting a proinflammatory status. Moreover, the pro-inflammatory response in female offspring perinatally dosed with GEN was supported by a decreased IgM level, as IgM has been shown to protect against autoimmune diseases (Hampe, 2012) . A lack of IgM was also shown to correlate with increases in pathogenic IgG (Hampe, 2012) . This is in agreement with a reduced IL-10 level in females perinatally dosed with GEN, as IL-10 producing B cells suppress inflammation in various mouse models of autoimmune diseases (Hampe, 2012) . It is interesting to speculate that the IL-10 producing B cells are CD5 þ as discussed later (Yanaba et al., 2009 ). In addition, IL-10-deficient mice experience severe T1D accompanied with an increase in Th1 cytokines (Tian et al., 2001) , and the decrease in IgG 1 among males perinatally dosed with GEN implies a decreased Th2 response. In this study, no statistical significances in the insulin level, insulin autoantibody level, and histopathology were observed (data not shown), possibly due to the fact that the sera and tissue samples were collected at the end of study when most animals developed T1D. For splenic cell subpopulation, CD24 is a marker for mature T cell, while CD5 is a common marker for regulatory B cells (Yanaba et al., 2009) . In recent studies, it was found that CD5 þ cells were negatively associated with pro-inflammatory status in autoimmune disease (Baglaenko et al., 2015) . In our study, a decrease in CD5 þ
CD24
À and an increase in CD5 À CD24 þ splenic cells were identified in females following perinatal dosing with GEN, and consequently, a weakened regulation of autoimmune responses was observed as reflected by the exacerbation of T1D. This is in agreement with our finding that IL-10 was decreased in GEN exposed female offspring as the IL-10 producing regulatory B cell subset with a unique CD1d hi CD5 þ phenotype controls T cell-dependent inflammatory responses (Vighi et al., 2008) . In contrast, among male offspring, the decreases of both helper T cell and total T cell populations would suggest an antiinflammatory status, and thus were associated with a protective effect against T1D. At the same time, serum level of IL-1a was numerically reduced in GEN-exposed male mice. IL-1 receptor deficiency can slow the progression to diabetes in the NOD mouse (Thomas et al., 2004) , suggesting that GEN reduction of IL-1a might be a novel mechanism of action. In infants, diets play a major role in the alteration of GMB and metabolites (Del Chierico et al., 2015) . In the current study, perinatal GEN exposure in female offspring led to an alteration in GMB at PND 90. Importantly, the down-regulated mRNA expression of defensins, an antimicrobial peptide that is an essential component of intestinal innate immunity (Coretti et al., 2017) , has been observed in these mice. Interestingly, the production of antimicrobial peptides is decreased in NOD mouse compared with their mutated strain with lower susceptibility (Mullaney et al., 2018) . Defensin can stabilize the GMB (Coretti et al., 2017 , Salzman 2010 while the reduction of a-defensin is associated with gut dysbiosis (Wehkamp et al., 2005) . Among the few studies investigating ileum a-defensin mRNA expression, NOD mice showed a reduced expression as compared with the NOD-resistant mice (Daft et al., 2011) . The antiinflammatory effect of defensin was associated with an increased IL-10 production in humans (Kanda et al., 2011) . Consistently, a decreased IL-10 level in female offspring perinatally exposed to GEN was observed in our study, which might explain the pro-inflammatory response following perinatal GEN dosing in females. Moreover, IL-10 deficiency leads to an activation of immune system (Sellon et al., 1998) and dysbiosis, which can be restored by certain bacterial strains (eg Lactobacillus spp.) (Madsen et al., 1999) . The down-regulated expression of defensin in intestinal tissues in female offspring perinatally exposed to GEN might be related to the epidemiological evidence that soybased formula induced a higher T1D risk than milk-based formula (Strotmeyer et al., 2004) . After birth, the infant formula consumption, compared with breast feeding, was found to be detrimental to neonatal immune system development (Innis, 2007) , as breast milk can provide defensins that enables infants to ward off environmental pathogens (Walker and Iyengar, 2015) .
Our previous studies have identified that the immunomodulatory effect of adult GEN treatment toward protection against T1D in NOD mice is associated with the alteration of GMB (Guo et al., 2015) . The hypothesized mechanism in perinatal GEN modulation of T1D in female NOD offspring is depicted in Figure 8 . Despite some epidemiological studies suggest a potential detrimental effect of perinatal soy consumption on autoimmune diseases such as T1D, this current study is the first to: (1) reveal the susceptible window of exposure, (2) discover the sex dimorphic effect, (3) use the "omics" technique to explore the GMB-immune-transcriptomics consortium of T1D development, and provide solid data for future risk assessment of infant diet on increasing autoimmune diseases. This study can also serve as a model of studying immune-related diseases for other environmental chemicals (such as dietary supplement and endocrine disruptors) and contribute to the discovery of novel biomarkers for early disease detection.
This study, however, also has some limitations. For instance, the harvest of terminal blood and organs has forbidden us to detect a histopathological alteration of disease progression. More time points in sample collection would enable a better trajectory of biomarkers (such as GMB) and could be included in future studies. In addition, the causal effect of GEN-induced mRNA expression, GMB, and intestinal immunological changes are not examined and require future investigation.
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